References
- 1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2163-96. Erratum in: Lancet. 2013; 381(9867):628. AlMazroa, Mohammad A [added]; Memish, Ziad A [added]
- 2. Hinton R, Moody RL, Davis AW, Thomas SF. Osteoarthritis: diagnosis and therapeutic considerations. Am Fam Physician. 2002; 65(5):841-8
- 3. Simon C, Everitt H, van Dorp F, Burkes M. Oxford Handbook of General Practice, 14th ed, 2014; Oxford University Press; p. 512-513
- 4. Hampton SN, Nakonezny PA, Richard HM, Wells JE. Pain catastrophizing, anxiety, and depression in hip pathology. Bone Joint J. 2019; 101-B (7):800-807.
- 5. Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum. 1992; 35(1):1-10
- 6. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis. 1957; 16(4):494-502
- 7. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988; 15(12):1833-40.
- 8. Schiphof D, de Klerk BM, Kerkhof HJ, Hofman A, Koes BW, Boers M, et.al. Impact of different descriptions of the Kellgren and Lawrence classification criteria on the diagnosis of knee osteoarthritis. Ann Rheum Dis. 2011; 70(8):1422-7
- 9. Taruc-Uy RL, Lynch SA. Diagnosis and treatment of osteoarthritis. Prim Care. 2013; 40(4):821-36
- 10. van Spil WE, DeGroot J, Lems WF, Oostveen JC, Lafeber FP. Serum and urinary biochemical markers for knee and hiposteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthritis Cartilage. 2010; 18(5):605-12
- 11. Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest. 2006; 116(1):4-15
- 12. McAlindon TE, LaValley MP, Harvey WF, Price LL, Driban JB, Zhang M, et.al. Effect of intra-articular Triamcinolone vs Saline on knee cartilage volume and pain in patients with knee osteoarthritis: A randomized clinical trial. JAMA. 2017; 317(19):1967-1975
- 13. Grosser T et al, J. Clin. Invest. 2006, 116:4–15
- 14. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020; 180:114147
- 15. Machado GC, Abdel-Shaheed C, Underwood M, Day RO. Nonsteroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain. BMJ. 2021;372: n104